This test detects variations in the LPA gene. It identifies individuals who are at risk of having elevated plasma Lp(a) and greater than a two-fold risk of cardiovascular disease (CVD). Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.